Summary & Overview

CPT 0116U: Snapshot Oral Fluid Compliance Test

CPT code 0116U identifies a proprietary laboratory test — the Snapshot™ Oral Fluid Compliance assay from Ethos Laboratories — that combines oral fluid drug screening with an algorithmic analysis to assess medication compliance and potential drug–drug interaction risk. As a PLA code, it is unique to a single manufacturer and represents a growing category of lab services that pair biochemical testing with proprietary clinical algorithms. Nationally, such tests are notable for their implications on clinical decision support, laboratory reporting, and payer coverage policies.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical purpose and service model, common payer coverage considerations, and coding context. The publication outlines benchmarks and policy-relevant issues for PLA codes, explains typical sites of service and how the algorithmic component factors into clinical interpretation, and summarizes available payer approaches and potential prior authorization or documentation expectations.

This summary is intended for clinicians, billing staff, laboratory managers, and policy analysts looking for a national-level briefing on CPT code 0116U, its clinical role, and the payer landscape surrounding proprietary laboratory analyses.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare0116UCPTProprietary Laboratory Analysesoral fluid drug testclinical algorithmlaboratory servicescompliance testingdrug–drug interaction riskSnapshot Oral Fluid

Billing Code Overview

CPT code 0116U is a Proprietary Laboratory Analyses (PLA) code for the Snapshot™ Oral Fluid Compliance test from Ethos Laboratories. The service combines an oral fluid drug test with an algorithmic analysis that uses patient data and laboratory results to report patient medication compliance and risk of drug–to–drug interactions.

Service type: Laboratory test with algorithmic clinical interpretation
Typical site of service: Clinical laboratory or outpatient collection site (oral fluid specimen collection and laboratory processing)

Clinical & Coding Specifications

Clinical Context

A 46-year-old patient receiving chronic opioid therapy for chronic low back pain presents for routine monitoring and medication management. The prescriber orders the Snapshot™ Oral Fluid Compliance test from Ethos Laboratories (0116U) to confirm recent use of prescribed opioids, detect non-prescribed or illicit substances, and assess risk for drug–drug interactions using the laboratory result combined with the patient’s medication list and clinical data. An oral fluid specimen is collected at an outpatient clinic or external collection site; the specimen is sent to Ethos Laboratories. The lab performs targeted toxicology on the oral fluid and runs an algorithmic analysis incorporating the patient’s reported medications and test results to generate a compliance and interaction-risk report. Results are returned to the ordering clinician and integrated into the medication management visit to inform follow-up, such as adherence counseling, medication adjustments, or referral to addiction medicine if indicated.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier required/standard reporting	Use when no special circumstances apply.
`11`

Taxonomy Code	Specialty	Notes
207Q00000X	Pain Medicine	Common ordering specialty for chronic opioid monitoring.
207L00000X	Anesthesiology	Frequently manages chronic pain programs and may order compliance testing.
208D00000X	Psychiatry & Neurology (Psychiatry)	Orders testing for monitoring substance use disorder treatment or medication adherence.
207RP1001X	Physical Medicine & Rehabilitation	Manages chronic pain and functional restoration programs; may order testing.
2080P0206X	Addiction Medicine	Uses compliance and interaction-risk reports to guide treatment for substance use disorders.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`F11.20`	Opioid dependence, uncomplicated	Monitoring compliance with prescribed opioid therapy and detecting nonprescribed opioid use.
`F11.10`	Opioid abuse, uncomplicated	Used when concern exists for misuse; test can detect recent opioid ingestion and illicit opioid exposure.
`Z79.899`	Other long term (current) drug therapy	Indicates ongoing prescribed medication therapy where adherence monitoring is appropriate.
`R78.89`	Other specified abnormal findings of blood chemistry (used for abnormal toxicology results)	Coded when laboratory toxicology yields abnormal findings requiring further evaluation.
`F11.20`	Opioid dependence, uncomplicated	(Repeated for emphasis) See above.
`F10.20`	Alcohol dependence, uncomplicated	Used when combined substance use monitoring is indicated; oral fluid testing can include alcohol metabolites depending on panel.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80101`	Drug test, qualitative; multiple drug classes by high complexity method, includes presumptive and definitive testing as defined by payer	May be ordered alongside or prior to `0116U` when facility performs standard lab toxicology panels instead of proprietary PLA testing.
`80307`	Drug test, definitive, any number of drug classes by mass spectrometry, each drug class screened and confirmed	Used when definitive confirmation by mass spectrometry is required for specific analytes identified by the oral fluid screen; may follow `0116U` findings.
`36415`	Collection of venous blood by venipuncture	May be performed in the same visit when blood-based testing or additional labs are required in conjunction with oral fluid testing.
`99000`	Handling and/or conveyance of specimen for transfer from the physician's office to a laboratory	Billed when specimen shipping/handling fees are allowed by payer for sending the oral fluid specimen to the reference lab.
`99072`	Additional supplies, materials, and clinical staff time over and above that usually required, during a public health emergency	Rare; only relevant under specific emergency conditions per payer policy.